Teva and Procter & Gamble Form Joint Venture to Accelerate OTC Drug Sales
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 4 (Table of Contents)
Published: 11 Apr-2011
DOI: 10.3833/pdr.v2011.i4.1455 ISSN: 1756-7874
Section: Joint Venture
Fulltext:
Abstract
Teva Pharmaceutical Industries and Procter & Gamble (P&G) have joined forces to create an OTC joint venture outside of North America as part of a novel partnership to capture a larger share of the OTC healthcare market, which is currently worth almost US$200 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS